Micro Labs Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Voglinorm GM 2/0.3 Tablet SR is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Voglinorm GM 2/0.3 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Voglinorm GM 2/0.3 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Voglinorm GM 2/0.3 Tablet SR.
Voglinorm GM 2/0.3 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Voglinorm GM 2/0.3 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Voglinorm GM 2/0.3 Tablet SR is a combination of three antidiabetic medicines.
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Voglinorm GM 2/0.3 Tablet SR contains a combination of Glimepiride, Metformin, and Voglibose. This medicine is used to treat type 2 diabetes mellitus (DM). It helps improve blood glucose levels in adults when taken with proper diet and exercise. Glimepiride lowers blood sugar by increasing insulin release from the pancreas. Metformin reduces glucose production in the liver and improves insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels.
Possible side effects associated with Voglinorm GM 2/0.3 Tablet SR include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Avoid using this medicine if you have a known allergy to any of its components or excipients. Patients with moderate to severe kidney disease and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis including diabetic ketoacidosis should avoid this medication.
No, consuming alcohol alongside Voglinorm GM 2/0.3 Tablet SR is not recommended. It may lower blood sugar levels further and increase the risk of lactic acidosis.
Yes, Voglinorm GM 2/0.3 Tablet SR can lead to hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, a fast heart rate, and feeling anxious or shaky. This is more likely when skipping meals, drinking alcohol, exercising excessively, or taking other antidiabetic medications alongside it. Regular monitoring of blood glucose levels is essential. Keep glucose tablets, honey, or fruit juice readily available.
Store this medicine in its original packaging, tightly closed. Follow the instructions on the label regarding storage. Do not consume any unused medicine. Keep it out of reach of pets, children, and other people.